NCT04269941

Brief Summary

Gastrointestinal stromal tumor (GIST) is the most common non-epithelial mesenchymal tumor of the gastrointestinal tract. Surgical treatment is the only curative therapy for primary localized GIST. This study aimed to identify the clinicopathological characteristics of gastric GISTs and to study the predictive factors for recurrence in Tunisian patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2000

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2000

Completed
15.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2015

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2018

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2020

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

15.1 years

First QC Date

February 12, 2020

Last Update Submit

February 12, 2020

Conditions

Gastric GIST

Outcome Measures

Primary Outcomes (1)

  • number of patients operated for gastric GIST

    the patient having adenocarcinoma or other histopathological type are excluded

    30 days

Study Arms (1)

prognostic factors of gastrointestinal stromal tumors

for the patient diagnosed with gastic GIST , they underwent subtotal or total gastrectomy.

Other: total or subtotal gastrectomy

Interventions

total or subtotal gastrectomyOTHER

resection of the gastric tumor

prognostic factors of gastrointestinal stromal tumors

Eligibility Criteria

Age10 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

There were 34 patients with the mean age of 58.2 years and male predominance. The disease was localized, locally advanced and metastatic in 26, 6 and 2 cases, respectively. Complete surgical resection was performed in 32 cases.

You may not qualify if:

  • patient operated for other gastric tumors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • ALI BEN ALI, PROFESSOR

    university of sousse

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

February 12, 2020

First Posted

February 17, 2020

Study Start

January 1, 2000

Primary Completion

January 29, 2015

Study Completion

January 2, 2018

Last Updated

February 17, 2020

Record last verified: 2020-02